CGIAR has partnered with global knowledge-driven media company, WebsEdge, to produce the With Science We Can Campaign – a multiplatform documentary campaign that will premiere at COP30 in Belém, Brazil. The CGIAR With Science We Can Campaign will serve as a unique platform to explore how we can achieve a food-secure future through scientific innovation.

Even expert witnesses called to offer crucial testimony in US court cases do not have to provide a written report of their findings. This is a professional failing that lowers standards, impedes accountability, and contributes to miscarriages of justice. Yet, it is one that is relatively simple to fix: Forensic scientists should be compelled to produce and publish written reports, which can then be peer-reviewed and corrected as necessary by others in the field.

A focused review on the regulation of plant gene editing, conducted by researchers Dr. Emily Buddle, Michail Ivanov, and Professor Rachel Ankeny of The University of Adelaide's School of Humanities, emphasizes the importance of clear regulations to ensure that new technologies are used safely and responsibly. The review, published in The Plant Journal, outlines the vital role of regulation in the innovation process by encouraging public involvement and building trust in emerging gene technologies

A study conducted by researchers from the National Insitute of Plant Genome Research (NIPGR), Indian Council of Agricultural Research (ICAR) National Rice Research Insitute (NRRI), and Regional Centre for Biotechnology in India shows that the overexpression of OsDUF2488 provides improved tolerance to dehydration and oxidative stress in rice. The results are published in Plant Biotechnology Journal.

In their study of wild wheat varieties that carry resistance to harmful pathogens, University of Saskatchewan (USask) researchers Dr. Valentyna Klymiuk and Dr. Curtis Pozniak discovered a unique pair of genes that work together to protect wheat against disease. From a wild strain of wheat, Klymiuk and Pozniak discovered significant resistance to stripe rust, a fungal disease considered one of the top five concerns for producers

GM soybean 305423xDAS-44406-6, developed by Corteva Agriscience, expresses genes that confer tolerance to acetolactate synthase inhibitors, glufosinate-ammonium, 2,4-D, and glyphosate-containing herbicides. It also expresses the gm-fad2-1 gene, resulting in an altered fatty acid composition. This GM soybean was developed by crossing the soybean lines 305423 and DAS44406-6 using conventional methods.

The license indicates that GM canola may be grown on an area of up to one hectare in 2025, and increasing to a maximum of 20 sites of up to five hectares each in 2029. The field trial will cover up to 206 hectares over five years, with possible field sites in New South Wales, Victoria, Western Australia, and South Australia. The primary goal of the trial is to evaluate the performance of GM canola under field conditions. The GM canola produced during the trial will not be used in commercial human food or animal feed.

As part of continued efforts to foster greater synergy with national partners in Africa, IITA Director General and CGIAR Regional Director for Continental Africa, Dr Simeon Ehui, held high-level meetings with key stakeholders in the Republic of Benin to strengthen partnerships and align agricultural innovations with national development priorities.

A new study published in the Journal of Cleaner Production presents a novel approach to sustainable agricultural intensification, with promising implications for food security and land conservation in Senegal. Conducted by researchers at the International Food Policy Research Institute (IFPRI), the study explores how farmers’ land-use decisions can be guided by the relative risks and returns of different crops—similar to how financial investments are managed.

A research team led by Prof. Won Do Heo from the Department of Biological Sciences at Korea Advanced Institute of Science & Technology (KAIST) has developed a technology that allows selective RNA modification in living cells and animals. The findings of the study, published in Nature Chemical Biology, mark a step forward in RNA-based gene therapy and precision medicine.